|
|
 |
|
Viewing report
|
|
|
|
2005 News in Review: Important Changes for the Pharmaceutical
Decision Resources, Inc., Dec 2005, Pages: 12
This report casts a look back at 2005 and reviews key events and issues in the news that have had a major impact on the pharmaceutical industry or will help shape the industry in the years to come. The report covers ten important news stories:
- The Vioxx withdrawal.
- The Tysabri withdrawal.
- The approval of BiDil for African-Americans.
- Medicare Part D.
- The drug reimportation debate.
- Controversy about political involvement in the drug approval process.
- Concerns about a flu pandemic.
- EU Pharmaceutical Review.
- Reference pricing for statins in Germany.
- Increased consolidation in Japan.
Customers who bought this item also bought
The Vioxx Withdrawal: Changes and Opportunities for the Industry
Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Second Quarter of 2007
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Third Quarter of 2007
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the First Quarter of 2007
Special Report: The Pandemic Paradigm: Balancing Commercial Opportunities with Public Health Concerns in the Face of A/H1N1 2009
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Fourth Quarter of 2006
Pricing & Reimbursement Series: Medicare Part Ds Progress So Far
Medicare Part D - Its impact on US drug pricing issues and role as a driver towards European style pricing mechanisms
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the First Quarter of 2008
Pipeline And Commercial Insight: Influenza Vaccines - Pandemic Threat Revitalizes The Sector
Pharmaceutical Regulatory Affairs in the EU & US
|
|
|
|
